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ttp://dx.doi.org/10.1016/j.ajpath.2013.04.023The goal of controlling ovarian cancer metastasis formation has elicited considerable interest in
identifying the tissue microenvironments involved in cancer cell colonization of the omentum.
Omental adipose is a site of prodigious metastasis in both ovarian cancer models and clinical
disease. This tissue is unusual for its milky spots, comprised of immune cells, stromal cells, and
structural elements surrounding glomerulus-like capillary beds. The present study shows the novel
ﬁnding that milky spots and adipocytes play distinct and complementary roles in omental metastatic
colonization. In vivo assays showed that ID8, CaOV3, HeyA8, and SKOV3ip.1 cancer cells prefer-
entially lodge and grow within omental and splenoportal fat, which contain milky spots, rather than
in peritoneal fat depots. Similarly, medium conditioned by milky spotecontaining adipose tissue
caused 75% more cell migration than did medium conditioned by milky spotedeﬁcient adipose.
Studies with immunodeﬁcient mice showed that the mouse genetic background does not alter
omental milky spot number and size, nor does it affect ovarian cancer colonization. Finally,
consistent with the role of lipids as an energy source for cancer cell growth, in vivo time-course
studies revealed an inverse relationship between metastatic burden and omental adipocyte
content. Our ﬁndings support a two-step model in which both milky spots and adipose have speciﬁc
roles in colonization of the omentum by ovarian cancer cells. (Am J Pathol 2013, 183: 576e591;
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Current address of M.S. and I.R., Department of Natural Sciences,
Stanford University, Stanford, CA.It is estimated that 22,240 women will be diagnosed with
and 14,030 women will die of cancer of the ovary in 2013
(http://seer.cancer.gov/csr/1975_2009_pops09, last accessed
June 18, 2013). The majority of patients present with metas-
tases or eventually die of metastatic disease within the
abdominal cavity. After escape from the primary tumor,
ovarian cancer cells in the peritoneal ﬂuid have access to andstigative Pathology.
.
Ovarian Cancer Colonizes Milky Spotscan potentially lodge within a variety of tissues.1,2 In both
clinical disease and experimental models, however, the
omentum is the site of prodigious metastasis formation.3e6
Thus, attachment of ovarian cancer cells to the omentum
represents an early step in the development of widespread
peritoneal disease.7,8 Although the importance of the omentum
is widely acknowledged, there still is no consensus on its role
in metastasis formation. This raises the question of what
components of the omental tissue microenvironment partici-
pate in, or facilitate, ovarian cancer metastatic colonization.
Studies of omental function date back to the early 19th
century. Jobert de Lamballe, a 19th-century surgeon in
France, was reportedly the ﬁrst to recognize the curious
ability of this organ to ﬁght infection and form adhesions to
help control injuries.9 After nearly two centuries of inves-
tigation, a great deal is known about the physiology and
surgical applications of the omentum.9e12 As the central
regulator of peritoneal homeostasis, its functions include
regulating ﬂuid and solute transport, sensing and repairing
injuries, promoting angiogenesis, ﬁghting infection, serving
as a source of stem cells, producing regulatory molecules,
and storing and supplying lipids. These diverse functions
are conferred by the cellular composition and architecture
characteristic of human omenta.
Aside from the clear collagenous membrane that acts as
a scaffold for the organ, the majority of the omentum is
composed of bands of adipose tissue that contain adipocytes,
blood and lymph vessels, immune cells, stromal cells, and
connective matrix components that lie beneath an irregular
mesothelium.13 In general, adipocytes have a variety of
functions, ranging from lipid storage to production of endo-
crine molecules, and can serve as an integrating hub for
inﬂammation, metabolism, and immunity.2,14e23 A distinc-
tive feature of the omental vasculature is the presence of
numerous branching blood vessels ending in tortuous
glomerulus-like capillary beds near the tissue periphery.24e28
Immune cells aggregate around and within these capillary
beds to form milky spots, which are the major immune
structure for host defense of the peritoneal cavity.24,29e36
In milky spots, both the endothelial lining of the capillaries
and the overlying mesothelium are specially adapted to
facilitate transmigration of immune cells.24,37,38 Additional
structural elements include plasmocytes, ﬁbroblasts, and
mesenchymal cells, as well as collagen and reticular and
elastic ﬁbers.29,34,37,39
A comprehensive literature review showed that studies
examining the role of the omentum in metastasis focus on the
contribution of its individual components, and not on the tissue
as a whole. In our view, results from the majority of studies
support models in which ovarian cancer metastatic coloniza-
tion is driven either purely by milky spots or purely by
adipocytes. The milky spotedriven model is based on a large
body of in vivo data showing that, on intraperitoneal injection,
cancer cells rapidly and speciﬁcally localize, invade, and
proliferate within omental milky spots.3,6,24,28,40e44 In contrast,
the adipocyte-driven model is based on the observation that, inThe American Journal of Pathology - ajp.amjpathol.orgits resting state, the omentum is composed predominantly of
adipose and that cultured adipocytes can produce adipokines
capable of promoting ovarian cancer cell migration and inva-
sion in vitro.45 Adipocytes can also provide a proliferative
advantage by transferring fatty acids to ovarian cancer cells.45
Although both models have clear strengths, neither addresses
the intimate and dynamic interaction among milky spots, sur-
rounding adipocytes, and other components of omental tissues.
Taking tissue architecture and function as a guide, we
propose that an alternative, more fully integrated model of
metastatic colonization is needed. To test this idea, we iden-
tiﬁed peritoneal fat depots (omentum, mesentery, and uterine,
gonadal, and splenoportal fat) that are accessible to ovarian
cancer cells after intraperitoneal injection.2 Of these, the
omentum and splenoportal fat are reported to contain milky
spot structures.24,46 We reasoned that a comparison of perito-
neal adipose that either contains or lacks milky spots could be
used to determine the contributions of adipocytes and milky
spots to the lodging and progressive growth of ovarian cancer
cells in physiologically relevant tissues. In vivo studies using
a panel of ovarian cancer cell lines showed that milky spots
dramatically enhance early cancer cell lodging on peritoneal
adipose tissues. Consistent with this ﬁnding, conditioned
medium from milky spotecontaining adipose tissue had a
signiﬁcantly increased ability to direct cell migration, com-
pared with conditioned medium from milky spotedeﬁcient
adipose tissue. Studies using a panel of immunodeﬁcient mice
showed that the number and size of omental milky spots is not
dependent on the mouse genetic background and, similarly,
that ovarian cancer cell colonization does not depend on the
immune composition of the milky spot. Finally, consistent
with the role for lipids as an energy source for ovarian cancer
cell growth, in vivo time-course studies revealed an inverse
relationship between metastatic burden and adipocyte content
in the omentum. Our ﬁndings support a two-step model in
which both milky spots and adipose have speciﬁc roles in
colonization of the omentum by ovarian cancer cells.
Materials and Methods
Cell Lines
The SKOV3ip.1 human ovarian carcinoma cell line47 was
generously supplied by Dr. Gordon Mills (MD Anderson
Cancer Center, Houston, TX). These cells were maintained in
standard growth medium [Dulbecco’s modiﬁed Eagle’s
medium (DMEM) containing 4.5 g/L D-glucose, 584 mg/L
L-glutamine, and 110 mg/L sodium pyruvate (Mediatech,
Manassas, VA), supplemented with 5% fetal bovine serum
(Atlanta Biologicals, Lawrenceville, GA), and 1% penicillin/
streptomycin (P/S) solution (a mixture of 5000 IU/mL peni-
cillin and 5000 mg/mL streptomycin), 1 nonessential amino
acids, and 2 minimum essentials medium vitamin solution
(all from Mediatech)]. The HeyA8 human ovarian carcinoma
cell line (ATCC, Manassas, VA) was maintained in standard
growth medium [DMEM supplemented with 5% fetal bovine577
Clark et alserum, 1% P/S, 1 nonessential amino acids, and 1
minimum essentials medium vitamin solution]. The CaOV3
human ovarian carcinoma cell line (ATCC)wasmaintained in
standard growth medium [DMEM supplemented with 8%
fetal bovine serum and 1% P/S]. The ID8 mouse ovarian
carcinoma cell line, derived from and syngeneic to mice of the
C57BL/6 background,4 was generously provided by Dr.
Katherine Roby (University of Kansas Medical Center,
Kansas City, KS). These cells were maintained in a standard
growth medium [DMEM supplemented with 4% fetal bovine
serum, 1% P/S solution, and 5 mg/mL insulin-transferrin-
sodium selenite (Roche Diagnostics, Indianapolis, IN)]. ID8
cells that stably express tdTomato (ID8-tdTomato) were
constructed by lentiviral delivery of pLVX-tdTomato
expression vector (Clontech, Mountain View, CA) followed
by selection for puromycin resistance. In brief, 3 mg of pLVX-
tdTomato and 9 mg of ViraPower lentiviral packaging mix
(Life TechnologieseInvitrogen, Carlsbad, CA) was trans-
fected into HEK293T cells to generate the viral conditioned
medium. The ID8 cells were transduced with the viral
medium and established by selection in medium containing
0.6 mg/mL puromycin. Fluorescence-activated cell sorting
using a BD FACSAria II system (BD Biosciences, San Jose,
CA) at the University of Chicago Flow Cytometry Core
Facility was used to select for high tdTomato-expressing cells.
All cells were maintained under standard tissue culture
conditions (ie, in a humidiﬁed incubator at 37C supple-
mented with 5% CO2).
Mice
All mice were housed, maintained, and euthanized accord-
ing to Institutional Animal Care and Use Committee
guidelines and under the supervision of the University of
Chicago Animal Resource Center. Outbred CD1 mice were
obtained from Charles River Laboratories International
(Wilmington, MA). Inbred B6 (C57BL/6NHsd; immuno-
competent), Nude (Athymic Nude-Foxn1nu; T-cell deﬁ-
cient), and BN XID (Hsd:NIHS-LystbgFoxn1nuBtkxid;
NK-cell and T-cell deﬁcient) mice were obtained from
Harlan Laboratories (Indianapolis, IN). Rag1 (B6.129S7-
Rag1tm1Mom/J; with no mature T or B cells, no CD3-positive
cells, and no T cell receptor a-bepositive cells) and Igh6
(B6.129S2-Ighmtm1Cgn/J; lacking mature B cells) mice were
obtained from Jackson Laboratories (Bar Harbor, ME).
Harvesting Mouse Tissues
The locations of the well-deﬁned adipose depots used for
the present studies have been described previously.2 Omenta
were harvested as described by Khan et al.6 Splenoportal fat
bands were collected by isolating the thin fatty band of
tissue connecting the hilum of the spleen to the pancreas,46
releasing it from the pancreas, and then carefully dissecting
it from the spleen. Uterine fat was excised from the uterine
horns using dissecting scissors; gonadal fat was similarly578excised from the ovaries. Mesenteries were collected by ﬁrst
cutting the junction between the small intestine and the
pylorus, ﬁrmly gripping the free end of the small intestine
with forceps, peeling the small intestine from the mesentery
by pulling the tissue slowly, and ﬁnally releasing the
mesentery from the mesentery root using dissecting scissors.Preparation of Tissues for Standard Histological
Evaluation
Tissues were processed for histological evaluation immedi-
ately after harvest or ex vivo culture. Larger tissues (whole
gonadal fat, uterine fat, and mesentery) were ﬁxed in 10%
neutral buffered formalin (Sigma-Aldrich, St. Louis, MO) for
48 hours at 4C. Smaller tissues (whole omentum, spleno-
portal fat, and tissue equivalents of uterine fat and mesentery)
were ﬁxed overnight (12 to 16 hours) in 5% neutral buffered
formalin (Sigma-Aldrich) at 4C. Fixed tissue was stored in
70% ethanol at 4C until parafﬁn embedding. Tissues were
sectioned (4 mm thick) and stained with H&E at the University
of Chicago Human Tissue Resource Center. Histological
evaluation of tissues was performed by a pathologist (M.C.)
under masked conditions.Immunohistochemistry
Tissue sections were deparafﬁnized in xylenes and rehy-
drated through serial dilutions of ethanol to distilled water.
Sections were subsequently incubated in antigen retrieval
buffer (Dako, Carpinteria, CA) and heated in a steamer to
97C for 20 minutes. Primary antibodies were diluted in
Tris-buffered saline and Tween 20 with 0.025% Triton X-
100. Pancytokeratin (clone H-240; sc-15367; Santa Cruz
Biotechnology, Santa Cruz, CA) and CD45 (clone H130;
14-0459-82; eBioscience, San Diego, CA) were applied to
tissue sections at a 1:100 dilution and incubated for 1 hour
at room temperature. After application of primary antibody,
slides were rinsed in Tris-buffered saline, and then bio-
tinylated secondary antibody diluted in Tris-buffered saline
and Tween 20 (with 10% mouse serum; Jackson Immuno-
Research, West Grove, PA) was applied to the slides.
For pancytokeratin staining, sections were incubated with
goat anti-rabbit IgG (1:200 dilution; BA-1000; Vector
Laboratories, Burlingame, CA) for 30 minutes at room
temperature. For CD45 staining, sections were incubated with
anti-mouse IgG (1:100 dilution; BA-2001; Vector Laborato-
ries) for 30 minutes at room temperature. The biotinylated
secondary antibody was detected using a Vectastain Elite
ABC kit (Vector Laboratories) and 3,30-diaminobenzidine
(DAB; Dako) peroxidase substrate. Cytokeratin 8/18
(TROMA-1; Developmental Studies Hybridoma Bank,
University of Iowa, Iowa) was applied undiluted on tissue
sections for 1 hour. Antigeneantibody binding was detected
using a Bond Polymer Reﬁne Detection system (DS9800;
Leica Biosystems, Buffalo Grove, IL).ajp.amjpathol.org - The American Journal of Pathology
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Aperio ScanScope XT instrument (Aperio Technologies,
Vista, CA) at 20 magniﬁcation. An Aperio color deconvo-
lution algorithm (Color Deconvolution version 9.1; Aperio
Technologies) was used for analyzing each omentum for
oxidized DAB intensity. The input parameters for each
channel (hematoxylin and DAB) were separately calibrated
before the analysis. Digital scan of each omentumwas selected
using the pen tool within the ImageScope viewing software
version 11.1.2.752 (Aperio) and analyzed for intensity levels
on a four-point scale (3 Z strong staining, 2 Z medium
staining, 1Z weak staining, and 0Z no staining). Intensity
was reported as percentage of cells with strong plus medium
DAB staining, normalized to the total stained area.
Peritoneal Metastasis Assay
Exponentially growing SKOV3ip.1, HeyA8, CaOV3, or
ID8 cells were trypsinized and prepared as a single-cell
suspension at a concentration of 2  106 cells/mL in ice-
cold PBS. Animals were injected intraperitoneally with 500
mL of the cell suspension (1  106 cells) at a point equi-
distant between the inguinal papillae. For all experiments,
500 mL of ice-cold PBS was injected as a negative control
in a parallel group of control mice. At the experimental
endpoint of each assay, mice were sacriﬁced via CO2
asphyxiation and vital organs were removed. Tissues were
then harvested, processed, sectioned, and stained as
described above.
Tissue Dissociation and Flow Cytometry
B6 mice were injected intraperitoneally with either PBS or
1  106 ID8-tdTomato cells. At 7 days post injection (dpi),
animals were sacriﬁced and peritoneal fat depots were
excised and immediately placed in ice-cold PBS. Tissues
were subsequently transferred to separate 5-mL Eppendorf
tubes containing 3 mL of serum-free (SF) DMEM con-
taining 0.2% (w/v) collagenase I (Worthington Biochemical,
Lakewood, NJ) and 0.1% (w/v) bovine serum albumin
(Sigma-Aldrich). The tissues were then minced using
surgical scissors, and the tissue suspension was incubated at
37C for 30 minutes with rotational mixing. To enhance
tissue dissociation, the digested tissue was transferred to
a microstomacher bag and masticated in a Stomacher 80
Biomaster system (Seward, Worthing, UK) on low for 10
minutes, rotating bags after 5 minutes.
To ensure a sufﬁcient yield of cells for ﬂow cytometry,
cell suspensions prepared from tissues harvested from three
independent mice were pooled to form one sample. Pooled
samples were ﬁltered through a nylon mesh ﬁlter (60-mm
pore) to remove larger debris. To collect the cellular
component of the digestion, the ﬁltrate was centrifuged at
250  g for 5 minutes; the supernatant fraction was
removed and discarded. To lyse RBCs, the cell pellet was
resuspended in 100 mL PBS combined with 900 mL ACKThe American Journal of Pathology - ajp.amjpathol.orglysing buffer (Invitrogen) and was incubated at room
temperature for 1 minute. Cells were collected for ﬂow
cytometric analysis by centrifugation at 250  g for 5
minutes; the supernatant fraction was removed and dis-
carded. The remaining pelleted cells were resuspended in
250 mL ice-cold PBS. Finally, to ensure that no clumped
cells remained, the cell suspension was passed through
a ﬁlter (60-mm pore) and the ﬁlter was rinsed with 250 mL
ice-cold PBS. The cell suspension was analyzed for the
presence of tdTomato-labeled cells using an LSRII ﬂow
cytometer (BD Biosciences) equipped with a 561-nm
yellow-green laser and a 585 nm/15 nm bandpass ﬁlter.
The tdTomato-positive gate was based on analysis of
parental ID8 cells. Data are expressed as fold change in ID8-
tdTomato cell-injected mice relative to PBS-injected control
mice (n Z 3 pooled samples for control mice and n Z 5
pooled samples for ID8-tdTomato celleinjected mice).
Preparation of Tissue-Conditioned Medium
Tissues harvested under sterile conditions were immediately
placed in ice-cold, sterile PBS. After collection, tissue
equivalents were prepared by ﬁrst weighing the omentum
from an individual mouse and then excising a strip of
uterine fat or branch of mesentery of equivalent weight. In
our studies, a single band of splenoportal fat weighed
2.90  0.62 mg (means  2 SD). Given that this is
approximately one half the weight of an omentum (6.72 
2.82 mg), two fat bands were combined to make one tissue
equivalent. Each tissue equivalent was placed in its own
well of a polystyrene 12-well plate containing 1.25 mL
DMEM/F-12 medium supplemented with 20% fetal bovine
serum and 1% P/S and was incubated at 37C in a 5%
CO2eenriched atmosphere, as described by Khan et al.
6
Tissues were allowed to acclimate to these ex vivo condi-
tions for 24 hours, after which the serum-containing
medium was removed; the tissues were then carefully
rinsed with PBS and placed in 1.25 mL SF DMEM/F-12
medium (containing 1% P/S). After 24 hours of condi-
tioning, the SF medium was collected and used for Trans-
well migration assays (described below).
For longer ex vivo culture, the medium was changed to
fresh SF DMEM/F-12 medium at subsequent 24-hour
intervals, such that the tissues were fed for the ﬁrst
24 hours and starved for the remainder of the assay.
Conditioned medium from each 24-hour interval was
collected. To ensure that stimulatory activity in the
conditioned medium was due to secretion of chemotactic
factors and not to cellular breakdown, tissue integrity was
assessed by H&E staining and light microscopy, as
described by Khan et al.6 Tissue function was also
conﬁrmed by measuring IL-6 levels in the conditioned
medium. IL-6 is produced by adipose, mesothelial cells,
and immune cells and is immediately secreted into the
microenvironment.48 Speciﬁcally, enzyme-linked immu-
nosorbent assays (ELISA) for IL-6 were performed on579
Clark et altissue-conditioned medium using a Mouse IL-6 Platinum
ELISA kit (eBioscience, San Diego, CA) according to the
manufacturer’s instructions.
Transwell Migration Assay
All migration assays used the same physical setup, with 1 mL
of conditioned or control medium (unconditioned SF culture
medium) to be tested for chemoattractant activity placed in
a well of a 12-well plate acting as the lower chamber. Cancer
cells were placed in the upper chamber consisting of a PET 8
mm pore membrane in a suspended from an insert scaffold
(Corning Life Sciences, Lowell, MA). Exponentially
growing SKOV3ip.1 or ID8 cells were trypsinized and
resuspended in SF DMEM at a concentration of 3.33  105
cells/mL or 2.50  105 cells/mL, respectively. In each case,
600 mL of cell suspension (SKOV3ip.1, 2.0 105 total; ID8,
1.5  105 total) was added to the upper chamber. Cells were
allowed to migrate in response to signals from conditioned or
control medium for 6 hours under standard tissue culture
conditions.
After incubation, medium was aspirated from both
chambers, and the upper and lower surfaces of the mem-
brane were washed once with ice-cold PBS. The membrane
was ﬁxed in 10% buffered formalin for 10 minutes at room
temperature. Residual formalin was removed by washing
with ice-cold PBS. Both sides of the membrane were
subsequently stained with 0.05% crystal violet solution
(Thermo Fisher Scientiﬁc, Waltham, MA) for 30 minutes at
room temperature and then washed once with tap water.
Cells that had not migrated through the membrane were
removed by gently wiping the upper membrane surface with
a cotton swab; the membrane was then allowed to air-dry
overnight. Finally, the membrane was removed from the
Transwell scaffold using a scalpel and was mounted with
the top surface facing up onto a slide using Permount
mounting medium (Thermo Fisher Scientiﬁc). Five random
images were captured per slide at 100 magniﬁcation with
a Zeiss Axiovert 200M inverted microscope (Carl Zeiss,
Jena, Germany) at the University of Chicago Integrated
Microscopy Core Facility, and the number of cells that had
migrated through the membrane was quantiﬁed. ImageJ 64
software version 1.45s (NIH, Bethesda, MD) was used to
quantitate the total number of migrated cells present in each
image. The counts from each of the ﬁve images were
summed to give the number of migrated cells for each
sample (n Z 5 for all conditions).
Milky Spot Identiﬁcation Using Carbon Nanopowder
Uptake
Carbon nanopowder was used to visualize omental milky
spots, essentially as described previously.29 In brief, carbon
nanopowder (<50-nm particle size; Sigma-Aldrich) was
mixed with PBS at a concentration of 5 mg/mL and was
sonicated for 20 minutes to produce a homogenous580suspension. The suspension was autoclaved, allowed to cool
to room temperature, and resonicated for 20 minutes imme-
diately before injection. Mice were intraperitoneally injected
with 800 mL of the carbon suspension. At 14 dpi, mice were
euthanized. Omenta were harvested and ﬁxed in 10%
formalin for 2 hours at room temperature. Whole ﬁxed tissue
was dehydrated through increasing concentrations of ethanol
(70%, 90%, 100%, and 100%; 10 minutes each) and was
cleared in xylene for 10 minutes. Tissues were then whole-
mounted between a slide and coverslip using Permount
medium. Images of the whole-mounted tissues were captured
using a CRi Pannoramic Scan Whole Slide Scanner at the
University of Chicago Light Microscopy Core Facility, and
images were processed with Pannoramic Viewer software
version 1.15.2 (3DHistech, Budapest, Hungary).
Milky Spot Identiﬁcation Using Giemsa Staining
Excised omenta were prepared for standard histological
evaluation, with careful orientation of the tissues during
parafﬁn embedding to produce longitudinal sections. The
whole omentum was serially sectioned at 4-mm thickness,
and every third section was Giemsa stained (Fluka; Sigma-
Aldrich). Slides were deparafﬁnized in xylenes and rehy-
drated through serial dilutions of ethanol to water. Slides
were stained in 5% Giemsa solution (prepared in tap water)
for 4 minutes, rinsed in tap water for 60 seconds, allowed to
air-dry, and mounted using Permount. Images of the stained
slides were captured using a CRi Pannoramic Scan Whole
Slide Scanner and were processed with Pannoramic Viewer
software (3DHistech).
Three-Dimensional Rendering of Giemsa-Stained
Omentum
ImageJ software was used to render a three-dimensional
image of a B6 omentum. Imaged, Giemsa-stained omentum
sections from an entire omentum were aligned using the
StackReg plug-in.49 The resulting stack was inverted and
the 3D Project tool, with the Interpolate function set to
a slide spacing of 4 mm, was used to render a three-
dimensional image. This was converted to 8-bit grayscale
and was false-colored using the Union Jack color scheme.
Milky Spot Identiﬁcation and Quantitation in
Giemsa-Stained Omentum
ImageJ software was used to quantify milky spot volume in
Giemsa-stained omental sections. Images were converted to
8-bit grayscale and inverted. The color balance was adjusted
to increase the contrast between the milky spots and
surrounding tissue. The image was converted to binary
format, to reduce background noise, and then was inverted
again. The threshold was set using the Auto function,
resulting in an image in which milky spots are pure black
and the rest of the tissue is pure white. The immuneajp.amjpathol.org - The American Journal of Pathology
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function. This was repeated for each of the Giemsa-stained
sections from each omentum. For each omentum, milky spot
areas per section were multiplied by 4 mm and summed to
yield a total milky spot volume.
The whole omentum volume was measured by adjusting
the brightness and contrast of the grayscale image to darken
the immune aggregates. The threshold was set to include the
entire tissue, and the image was converted to a pure black
mask. To make a cohesive border for the omentum, the Find
Edges tool was applied, and the image was again converted
to a mask and the Fill Holes function was selected. Again,
the omentum was quantiﬁed using the Analyze Particles
function. Particles smaller than 25 pixels were excluded
from the analysis, to reduce background noise. Areas for
each omentum were multiplied by 4 mm and then were
summed to yield a total whole omentum volume (n Z 5
omenta per mouse strain).
Quantitation of Adipocyte Area in Omentum Over the
Time Course of Metastatic Colonization
Omenta were harvested frommice at 1, 3, 6, and 9weeks after
ID8 cancer cell injection into B6 mice, and tissues were
prepared for standard histological evaluation. H&E-stained
sections were imaged using a CRi Pannoramic Scan Whole
Slide Scanner. With ImageJ software, section images were
converted to 8-bit grayscale, the brightness and contrast were
adjusted to darken the nonadipocyte tissue, and the image
threshold was set (using the Auto function) such that only
nonadipocyte structures were transformed to pure black.
These structures were measured using the Analyze Particles
function, with particles smaller than 25 pixels excluded.
Resulting areas were summed to produce a total nonadipocyte
area. The whole omentum was measured by adjusting the
threshold of a brightness- and contrast-adjusted grayscale
image such that the whole area was converted to pure black.
Again, the omentum was quantiﬁed using the Analyze
Particles function, excluding particles smaller than 25 pixels
and with the Include Holes option selected. Resulting areas
were summed to yield a total omentum area. The percentage
of adipocytes was calculated by subtracting the total non-
adipocyte area from the total omentum area and dividing that
difference by the total omentum area. Three sections were
quantiﬁed per mouse, with nZ 5 mice per time point.
Macros for the several image processing steps are
provided in Supplemental Table S1.
Statistical Analysis
All statistical analyses were performed using GraphPad
Prism software version 5.0f (GraphPad Software, La Jolla,
CA). Statistical signiﬁcance was determined using one-way
analysis of variance followed by TukeyeKramer multiple
comparison tests. Data are expressed as means  SEM of
biological replicates.The American Journal of Pathology - ajp.amjpathol.orgResults
Several Sources of Adipose Tissue Are Accessible to
Ovarian Cancer Cells in the Peritoneal Cavity
The organ-speciﬁcity of ovarian cancer metastasis is often
explained by the anatomical location and tissue composition
of the omentum.5,44 To our knowledge, however, these
assertions have not been tested in vivo by evaluating ovarian
cancer cell lodging or growth in other adipose depots that
are also accessible during peritoneal dissemination. There
are ﬁve major adipose depot structures in the peritoneal
cavity.2 A lateral view of a ventral dissection allows visu-
alization of the omentum, gonadal fat, uterine fat, and
mesentery (Figure 1A). Further dissection allows for clear
visualization of the splenoportal fat, which surrounds the
splenic artery and connects the hilum of the spleen to the
celiac artery (Figure 1B), and of the omentum, isolated from
the pancreas (Figure 1C). The gross structure and relative
size of these tissues can be seen in Figure 1D.
Interestingly, in 1995 Takemori et al46 reported the pres-
ence of milky spots in the splenoportal fat of New Zealand
Black mice that are similar in structure and composition to
omental milky spots previously reported in the literature. The
authors did not, however, examine cancer cell localization to
these structures. Our histological evaluation showed that both
the omentum and splenoportal fat have archetypal milky spot
structures, but these structures were not observed in uterine,
gonadal, or mesenteric fat (Figure 2A). Furthermore, at 7
days after intraperitoneal injection of SKOV3ip.1 cells,
similar cancer cell lesions were observed in both omental and
splenoportal fat (Figure 2B), but not in other fat depots. IHC
using a human pancytokeratin antibody showed that the
lesions were composed of epithelial (SKOV3ip.1) cells
intermingled with the immune cells. The speciﬁcity of IHC
staining was conﬁrmed using an IgG control for the pan-
cytokeratin antibody (Figure 2B).
Ovarian Cancer Cells Preferentially Colonize Peritoneal
Adipose That Contains Milky Spots
A review of the literature showed that the predilection of
ovarian cancer for omental metastasis formation can be
ascribed to either adipose-driven or milky spotedriven
mechanisms. However, these models are based on studies
focusing on either structural features (ie, milky spots)
or cellular components (ie, adipocytes) of omental
tissue.28,42,45 The availability of peritoneal fat depots that
contain or lack milky spot structures enabled us to distin-
guish experimentally between the two models in the phys-
iologically relevant setting of the peritoneal cavity. We
reasoned that if colonization were purely adipocyte-driven,
then ovarian cancer cells would colonize the various peri-
toneal adipose depots to a similar extent after intraperitoneal
injection. In contrast, if milky spots drive this process, then
the omentum and splenoportal fat would have cancer cell foci581
Figure 1 Relative locations of the main peritoneal adipose depots,
with ovary, uterine horn, and small intestine indicated as points of
reference. A: Left view of the peritoneal cavity of a B6 mouse, exposed
via a ventral incision. This gross anatomical dissection shows the
relative location of four of the ﬁve primary sources of peritoneal fat: the
omentum (OM; outlined), located above the stomach and spleen; the
gonadal fat (GF), surrounding the left ovary (ov); the uterine fat (UF),
attached to the left uterine horn (uh); and the mesentery (MY),
attached to the small intestine (si). B: The ﬁfth source of peritoneal
adipose is the splenoportal fat, which can be exposed by lifting the
spleen with forceps (SP; outlined). C: To improve visualization, the
mouse omentum here is dissected free from the pancreas. Although
analogous to the human omentum in composition and tissue architec-
ture, the mouse omentum consists of a single ribbon of fat attached to
the pancreas. D: The ﬁve sources of peritoneal fat are excised, to show
relative size. The mesentery is shown with attached mesenteric root. The
scale is marked in centimeters.
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582in their numerous milky spots, whereas uterine, gonadal, and
mesenteric fat would essentially be free of cancer cell colo-
nies. Although our studies using SKOV3ip.1 cells support
this latter model, determining the generalizability of these
ﬁndings requires further study using additional ovarian
cancer cell lines. To this end, the ability of ID8, CaOV3, and
HeyA8 cells to form cancer cell foci in the ﬁve distinct
peritoneal fat depots after intraperitoneal injection into B6
mice (ID8) or Nude mice (CaOV3, HeyA8) was assessed by
histology. The average number of cancer cells in a represen-
tative section of tissue was determined and expressed as foci
per slide (Supplemental Table S2). At 7 dpi, numerous large
foci of ID8 cells were seen within the milky spots of both the
omentum (mean, 48 foci per slide) and splenoportal fat
(mean, 5 foci per slide) (Figure 2C). No ovarian cancer cells
were detected in the uterine or gonadal fat (Figure 2C). In the
mesentery, small clusters (<10 cells) of cancer cells were
observed (mean, 2 foci per slide) on the tissue periphery
(Figure 2C). In accord with these ﬁndings, CaOV3 cells
showed similar pattern and extent of foci formation in the
peritoneal adipose (Figure 2C and Supplemental Table S2).
Interestingly, HeyA8 cells had a greater ability to form
surface foci on uterine fat, with a mean of 8 foci per slide
(Figure 2C and Supplemental Table S1).
Finally, to complement our ﬁndings from our histological
analyses and to enable further studies, we developed
a protocol to quantitate the number of cancer cells present
in peritoneal adipose depots. ID8-tdTomato cells were
prepared and injected intraperitoneally into B6 mice. At 7
dpi, the adipose organs were harvested and dissociated into
a single-cell suspension. The number of tdTomato cells
present in the population of remaining cells (eg, ﬁbroblasts
and immune, endothelial, and mesothelial cells) was quan-
tiﬁed via ﬂow cytometry. Splenoportal fat was excluded
because its small size prohibited reliable cell recovery.
Omental tissue preparations contained a signiﬁcant pop-
ulation of tdTomato-positive cells (Figure 2D). The
omentum showed an approximately 12-fold increase in the
number of tdTomato-positive events, relative to PBS-
injected controls (Figure 2D), but there was no signiﬁcant
increase in cell preparations from the gonadal fat, uterine
fat, or mesentery. These data support our histological
ﬁnding that ovarian cancer cells preferentially colonize
milky spotecontaining adipose and provide an additional
quantitative method for further studies by our research
group and others.
Omental Tissues Secrete a Factor or Factors That Can
Promote Ovarian Cancer Cell Migration
Ovarian cancer cells speciﬁcally localize to the omentum
within minutes after intraperitoneal injection.3,6,40 This
suggests that omental tissue produces a factor or factors that
promote cancer cell homing; however, previous studies have
examined only the contribution of isolated adipocytes.45 To
address this gap in knowledge, we ﬁrst tested the ability ofajp.amjpathol.org - The American Journal of Pathology
Figure 2 Ovarian cancer cells preferentially
colonize peritoneal adipose that contains milky
spots. A: Milky spots (MS) are observed in the
adipose (A) of the omentum and splenoportal fat of
PBS-injected and naïve mice. In contrast, no milky
spots were detected in the uterine fat, gonadal fat,
or mesentery (each of which is composed mostly of
adipocytes). Images are representative of PBS-
injected B6 mice. Blood vessels are indicated by
arrows. B: Examination of tissues by both standard
histology (H&E) and IHC [pancytokeratin (pan-CK)]
shows similar colonization of milky spots in both
omentum and splenoportal fat (after injection of 1
 106 SKOV3ip.1 cells into Nude mice). Sections
were ﬁrst evaluated by H&E staining. The presence
of epithelial (cancer) cells within the lesions was
conﬁrmed by IHC detection of cytokeratin using
a pancytokeratin antibody. IHC using an IgG iso-
type antibody for pancytokeratin was used as
a control for staining speciﬁcity. C: Evaluation of
ID8, CaOV3, and HeyA8 ovarian cancer colonization
of peritoneal fat depots at 7 dpi. Large cancer cell
lesions in the milky spots of both the omentum and
splenoportal fat are outlined. Representative
examples of the cancer lesions occasionally seen in
uterine, gonadal, and mesenteric fat are shown in
the corresponding insets. D: Flow cytometric anal-
yses of omentum, uterine fat, gonadal fat, and
mesentery harvested from mice at 7 dpi of ID8-
tdTomato cells. The quantiﬁed ﬂow cytometry
data are expressed as means  SEM for fold change
increase of tdTomato-positive events (grey bars)
relative to PBS-injected mice (white bars). **P <
0.01 versus PBS controls. Original magniﬁcation:
400 (A and C); 100 (B).
Ovarian Cancer Colonizes Milky Spotsomentum-conditioned medium to promote directed cancer
cell migration. Using a modiﬁcation of our published
method for ex vivo organ culture,6 omenta were excised and
allowed to normalize in DMEM/F12 medium containing
20% fetal calf serum for 24 hours. Tissues were then rinsed
with PBS, placed in SF DMEM/F-12 medium, and main-
tained for up to 5 days ex vivo. Tissue integrity was assessed
both histologically, by visually evaluating intact (round,
continuous cell membrane) versus necrotic (stellate,
discontinuous cell membrane) adipocytes, and functionally,
by measuring the level of IL-6 in the conditioned medium
every 24 hours. In accord with our previous studies,6
omental tissues did not show loss of integrity or function
under these conditions (Supplemental Figure S1).
After normalization in DMEM/F-12 medium containing
20% fetal calf serum, omenta were rinsed with PBS
and allowed to condition SF DMEM/F-12 medium for 24
hours (referred to as conditioned SF medium). OmentumThe American Journal of Pathology - ajp.amjpathol.orgmaintained in SF medium is termed starved omentum. The
combinations of omentum and medium used as chemo-
attractants for the 6-hour migration assay and representative
membranes from the migration assays are summarized in
Figure 3A. The number of cells that migrated to the lower
side of the membrane was determined by summing the
number of cells in each of ﬁve independent ﬁelds observed
at 100 magniﬁcation.
Initial studies tested the ability of omenta harvested from
CD1 mice to promote migration of both mouse ID8 and
human SKOV3ip.1 cells (Figure 3B). The CD1 conditioned
SF medium served as a strong chemoattractant for both ID8
and SKOV3ip.1 cells, resulting in a greater than 150-fold
increase in migration relative to SF medium controls.
To ensure that these results are not speciﬁc to omenta har-
vested from CD1 mice, conditioned SF media from B6 and
Nude mouse omenta were also tested in their ability to
promote ID8 and SKOV3ip.1 cell migration. Conditioned583
Figure 3 Milky spotecontaining adipose
tissues show enhanced ability to stimulate
directed migration. Transwell migration assays are
used as an indicator of soluble factors that
promote the directed migration of ovarian cancer
cells in tissue-conditioned medium. A, top row:
Migration assay setup. Cancer cells are placed in
the upper chamber of the Transwell apparatus. The
chemoattractant medium, with or without starved
tissue, is placed in the lower chamber. A, bottom
row: Representative membranes from ID8 migra-
tion assays. B: Quantitation of ID8 and SKOV3ip.1
cell migration in response to factors produced by
omenta harvested from CD1 mice under the four
conditions shown in panel A. C: Quantitation of
ID8 and SKOV3ip.1 cell migration in response to SF
medium conditioned by omentum from either B6
mice [CSF (B6)] or Nude mice [CSF (Nude)]. D:
Migration assay of ID8 cells toward SF medium
conditioned for 24 hours by tissue equivalents of
omenta, splenoportal fat, uterine fat, and mesen-
tery harvested from B6 mice. n Z 5 for all
conditions. Data are expressed as means  SEM.
***P < 0.001. CSF, omentum-conditioned SF
medium; SOM, starved omentum.
Clark et alSF media prepared from B6 and Nude mouse omenta were
a strong chemoattractant for ID8 cells (Figure 3C), stimu-
lating migration on par with CD1-conditioned medium
(Figure 3B). Consistent with this ﬁnding, B6 and Nude
conditioned SF media also stimulated equivalent levels of
migration in SKOV3ip.1 cells. Interestingly, SKOV3ip.1
cells showed a consistently lower level of migration than
ID8 cells in response to medium conditioned by omenta
from CD1, B6, and Nude mice. Taken together, these
experiments showed that intact omental tissue can be used
as a starting point for efforts to identify the secreted factor or
factors that promote ovarian cancer cell homing to omental
tissues.
Milky SpoteContaining Tissues Show Enhanced Ability
to Stimulate Directed Migration
Nieman et al45 showed that adipocytes cultured in vitro
secreted cytokines that can promote migration of
SKOV3ip.1 ovarian cancer cells. This raised the possibility
that migration of cancer cells toward omentum-conditioned
medium could be a strictly adipose-driven process. If that
were the case, medium conditioned by adipose tissue lack-
ing milky spots should promote migration of ovarian cancer
cells to the same extent as medium conditioned by milky
spotecontaining adipose tissue. Alternatively, if milky spots
play a key role in organ-speciﬁc homing, conditioned
medium from tissues containing milky spots should have an
enhanced ability to promote migration.584To distinguish between these possibilities, conditioned SF
medium prepared using weight-matched tissue equivalents
of omentum, splenoportal fat, uterine fat, and mesentery was
used as a chemoattractant in Transwell migration assays.
Tissues did not show loss of integrity or function for the
duration of the migration assay; however, IL-6 production
of the cultured uterine fat dropped signiﬁcantly at 3 days in
culture (Supplemental Figure S1). The migration-promoting
activity of conditioned SF medium prepared from each of
these tissues is summarized in Figure 3D. The medium
conditioned by omenta or by splenoportal fat caused a 95-
fold increase in cell migration, compared with control SF
medium. In contrast, the absence of milky spots in uterine
fat and mesentery corresponded with a 75% reduction in the
migration-stimulatory activity in their conditioned medium
(Figure 3D). Taken together, these functional studies bridge
the adipocyte-driven and milky spotedriven models and
argue that the presence of milky spots increases the che-
moattractive potential of peritoneal fat depots.
The Number and Size of Omental Milky Spots Is Not
Dependent on the Mouse Genetic Background
Immune cells, including macrophages, lymphocytes, and
mast cells, are integral to both the composition and function
of omental milky spots.29,34,37,39 There is a common view
that omenta from immunodeﬁcient mice will either have no
milky spots or signiﬁcantly fewer milky spots than omenta
from immunocompetant mice. To test this notion, we soughtajp.amjpathol.org - The American Journal of Pathology
Figure 4 An alternative protocol for labeling milky spots in mouse
omenta. A: A rare example of a whole mount of a B6 omentum with clear
milky spot labeling after carbon staining. B: A more typical case of a B6
omentum ineffectively stained, with several carbon plaques (arrows)
obstructing milky spot visualization. C: As an alternative to carbon
labeling, we developed a method in which naïve mouse omenta were
parafﬁn-embedded, sectioned at 4 mm, and stained with Giemsa. Dark
staining regions indicate dense areas of immune aggregates. D: Image of
omental tissue section stained with Giemsa. Milky spots are indicated with
arrowheads. E: Image of omental tissue section adjacent to that shown in
panel D, stained with H&E. F: Image of omental tissue section adjacent to
that shown in panel E, evaluated by IHC using anti-CD45 antibody to
identify lymphocytes within the milky spot structure. G: Mask of the
omentum section shown in panel C, processed so that milky spots are
speciﬁcally converted to pure black pixels. H: Mask of the omentum section
shown in panel C, processed so that the entire area of the omentum is
converted to pure black pixels. Scale bars: 1.0 mm (AeC, G, and H); 100
mm (DeF).
Ovarian Cancer Colonizes Milky Spotsto quantitate the number and/or size of milky spots in
omenta from a panel of immunodeﬁcient mice. The majority
of published studies use two standard methods to identify
milky spots. The ﬁrst uses a nonspeciﬁc esterase stain,
which colors macrophages and T-lymphocytes dark red.29
In our hands, this method yielded highly variable results
that were not of sufﬁcient quality or resolution for quanti-
tative analyses (data not shown). The second method uses
intraperitoneal injection of a carbon nanopowder suspen-
sion, which is phagocytosed by peritoneal macrophages
over a period of days and thus highlights milky spots.29
Tissues are subsequently harvested, whole-mounted, andThe American Journal of Pathology - ajp.amjpathol.orgthe number and/or area of the black-staining macrophages
are used as a measure of milky spot number and size. When
this method works correctly, the milky spot structures are
crisp and well deﬁned, and they can be visualized and
counted under light microscopy (Figure 4A). Nonetheless,
this technique can give inconsistent results, because carbon
plaques often form on various peritoneal surfaces
(Figure 4B). This plaque formation prevents both precise
isolation (excision) of the omentum and accurate evaluation
of milky spot area in the whole-mounted tissue.
To circumvent this difﬁculty, we developed a novel tech-
nique to visualize the milky spots on a whole-mount scale
using Giemsa staining. In this approach, excised omenta
were parafﬁn-embedded and the entire organ was serially
sectioned at 4 mm (resulting in approximately 30 to 60
sections). Every third section was stained in a 5% Giemsa
solution, and images of the stained tissues were captured
using a CRi Pannoramic Scan Whole Slide Scanner
(Figure 4C). Milky spots appear as regions staining dark blue
(Figure 4D). The identity of these regions as milky spots was
conﬁrmed in serial sections by both H&E staining and IHC
for cells positive for CD45, a common lymphocyte marker
(Figure 4, E and F, respectively). Milky spots from B6, Nude,
Rag1, Igh6, and BNXIDmice were successfully stained with
Giemsa using this method (Supplemental Figure S2). By
stacking and aligning all of the Giemsa-stained images from
one omentum, we were able to produce a three-dimensional
rendering of a mouse omentum that accurately depicts the
tissue architecture and presents a novel view of the location
and structure of milky spots (Supplemental Video S1).
We used ImageJ software to process the Giemsa-
stained omentum slices to produce images that display
both milky spots (Figure 4G) and the whole omentum area
(Figure 4H) as pure black pixels. (The processing steps
are detailed under Materials and Methods.) These black
pixels were quantiﬁed using the Analyze Particles func-
tion of ImageJ software, producing a milky spot area and
a whole omentum area for each slice. For each omentum,
the milky spot and whole omentum areas were summed
for all sections and the result was multiplied by 4 mm (the
section thickness), yielding milky spot and total volume
for each omentum. Surprisingly, we found no difference
in the milky spot volumes (Figure 5A) or the omentum
volumes (Figure 5B) for the ﬁve mouse strains. Further-
more, no signiﬁcant difference was found when the milky
spot volume was expressed as a percentage of the total
omentum area (Figure 5C). We therefore conclude that
there is no signiﬁcant difference in the milky spot volume
in omenta from C57BL/6, Nude, Rag1, Igh6, and BN XID
mice.
In vivo colonization of omental milky spots by ovarian
cancer cells is not dependent on their immune cell compo-
sition. As a ﬁrst step toward understanding the effect of the
immune cell composition of milky spot structures on
ovarian cancer cell colonization, experimental metastasis
assays were performed using immunocompetent (B6) and585
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Figure 5 The milky spot volume of the omentum is not affected by the immune status of the host. Giemsa-stained sections of omenta harvested from B6,
Nude, Rag1, Igh6, and BN XID mice were processed, sectioned, Giemsa stained, and imaged to determine the area of milky spots and the whole omenta area on
each section. A: Milky spot volume per omentum, calculated by multiplying the area of each section by 4 mm and summing the sections. B: Total volume of the
whole omentum. C: Milky spot volume as a percentage of the total omentum volume. For each mouse strain, milky spot and omental volumes were determined
for ﬁve independent animals. No measurements differed statistically among any of the mouse strains (one-way analysis of variance). Data are expressed as
means  SEM.
Clark et alimmunodeﬁcient (Igh6, Nude, Rag1, and BN XID) mice.
Speciﬁcally, 1  106 ID8 ovarian cancer cells were injected
intraperitoneally into mice of each of the ﬁve different
strains. Cancer cell foci were observed within milky spots in
each of these mouse strains at 7 dpi (Figure 6A) and were
conﬁrmed to be epithelial via positive staining for mouse
cytokeratin 8/18. To determine whether the missing
immune-cell types in the various immunodeﬁcient mice
alters cancer localization to milky spots, DAB area was
quantiﬁed in cytokeratin 8/18estained sections. ID8
cancer cells colonized omenta from each strain to a statisti-
cally equivalent degree (Figure 6B). In parallel, 1  106
SKOV3ip.1 human ovarian cancer cells were injected into
Nude, Rag1, and BN XID mice, and cancer foci were again
observed in each mouse strain (Figure 6C). SKOV3ip.1
lesions were stained for human pancytokeratin and found to
be cytokeratin-positive. Thus, ovarian cancer cell coloni-
zation of omental milky spots is not affected by deﬁciency
or absence of T cells, B cells, and/or NK cells in these
mouse strains.During Progressive Growth, Ovarian Cancer Cells
Replace Omental Adipose
Mechanistic studies by Nieman et al45 indicated that ovarian
cancer cells can use adipocytes as an energy source for
tumor growth. If this holds true in vivo, we predicted that as
cancer cells proliferate they interact with and consume
adipocyte lipids. The ultimate outcome of this inverse
relationship between cancer cell area and adipocyte area
would be that, at the experimental endpoint, the omental
adipose would be replaced completely with cancerous
tissue. To test this notion, 1  106 ID8 ovarian cancer cells
were injected intraperitoneally into a cohort of B6 mice.
Groups of ﬁve mice were euthanized and tissues were
collected for histological analysis at 1, 3, 6, and 9 weeks
after injection (Figure 7A). Consistent with an inverse
relationship between ovarian cancer cell growth and
adipocyte depletion, there was a marked reduction in the586adipocyte area over time. To quantify this change, we used
a pixel-based image processing protocol similar to milky
spot quantiﬁcation (detailed under Materials and Methods)
to calculate the adipocyte area in omenta over time. This
showed a linear decrease in the percentage of adipocytes in
the omentum, corresponding to the expansion of ID8 cancer
cell lesions (Figure 7B). These data are consistent with
cancer cell utilization of lipids stored in adipocytes as an
energy source for their continued growth.Discussion
There is now considerable literature on the structure and
function of milky spots in both the omentum and extra-
omental sites. Beginning in the 1970s, investigators noted
that ascites tumors have a proclivity for these structures,41
and subsequent studies have conﬁrmed and reﬁned these
ﬁndings.3,6,40 The strength of this work is that it implies
a functional role for milky spots in the early steps of omental
colonization. The weakness of the milky spotedriven model
is the fact that the studies on which it is based do not consider
the potential contributions of adipocytes and other cells
within the omentum. Although the failure to consider the
contribution of omental adipose in cancer metastasis is
consistent with the now-antiquated view of adipocytes as an
inert component of connective tissues,14,19,20 it is a funda-
mental oversight that must be addressed if we are to under-
stand the organ speciﬁcity of ovarian cancer cells.
The adipocyte-driven model was prompted by the ﬁnd-
ings of Nieman et al,45 who showed that in omental
metastases the ovarian cancer cells at the interface with
adipocytes contain abundant lipids. Their in vitro studies
showed that the adipocytes transfer to ovarian cancer cells
lipid droplets containing fatty acids,45 which can be used as
an energy source. The strength of their studies is that they
focused on human ovarian cancers and identiﬁed a novel
function for adipocytes in the progressive growth of ovarian
cancer lesions, and the weakness lies in the effort to show
that adipocytes drive, and are solely responsible for, earlyajp.amjpathol.org - The American Journal of Pathology
Figure 6 Colonization of omental milky spots by ovarian cancer cells is not dependent on the immune status of the host. To test the possibility that the
immune composition of the milky spots has a quantitative effect on ovarian cancer cell colonization, mice with deﬁciencies in T cells, B cells, and/or NK cells
were injected intraperitoneally with either PBS (control) or 1  106 ovarian cancer cells. A: B6, Igh6, Nude, Rag1, and BN XID mice were injected with mouse
ID8 cells (syngeneic to B6 background). Omenta were collected at 7 dpi and stained with H&E. Cancer cell foci are outlined. Immunohistochemistry (IHC)
against mouse cytokeratin 8/18 (CK8/18) was used to conﬁrm the epithelial origin of the cancer cell foci. B: DAB staining area was used as an indicator of
cancer cell burden in omental tissues. Values were calculated as the percentage of area with strong plus medium intensity of cytokeratin 8/18 (DAB) staining,
normalized to total stained area of the slide. C: Human SKOV3ip.1 cells were injected into Nude, Rag1, and BN XID mice. Omenta were collected at 7 dpi and
stained with H&E. IHC against human pancytokeratin was used to conﬁrm the epithelial origin of cancer cell lesions. Samples from ﬁve independent animals
were evaluated for each condition of each test. Data are expressed as means  SEM. Original magniﬁcation: 200.
Ovarian Cancer Colonizes Milky Spotssteps in omental colonization. The case for adipose as the
sole determinant of the organotropic metastasis of ovarian
cancer is based on an incomplete examination of the liter-
ature and on a biased approach to experimental design. As
a result of the focus on adipocytes, important clues in the
data were overlooked, and the potential contributions of
milky spots, vasculature, or other unique characteristics of
the omentum were neither tested nor discussed. Thus, like
the milky spotedriven model, the adipocyte-driven model
also is limited by the narrow focus of the studies on which it
is based.
Despite their strengths, neither the milky spotedriven nor
the adipocyte-driven model addresses the intimate and
dynamic interactions among milky spot structures, adipo-
cytes, and other omental components. Integration of theseThe American Journal of Pathology - ajp.amjpathol.orgtwo models requires a fresh look from a different perspec-
tive. Thus, rather than taking the more traditional omentum-
focused approaches, we sought to understand why ovarian
cancers do not colonize other sources of peritoneal fat as
extensively as they do the omentum. This led to our novel
strategy of comparing colonization of peritoneal adipose
that either contains or lacks milky spots. The report by
Takemori et al46 showing the presence of milky spots in the
splenoportal fat of New Zealand Black mice was key to our
approach. To our knowledge, the splenoportal fat band has
not been studied in other mouse strains, nor has its coloni-
zation by any type of cancer cells been examined previ-
ously. Our in vivo studies using a panel of ovarian cancer
cell lines (ID8, SKOV3ip.1, CaOV3, and HeyA8) yielded
the most comprehensive assessment of ovarian cancer cell587
Figure 7 Adipocyte area of the omentum decreases during the time course of ovarian cancer growth. A: A representative H&E-stained section of an
omentum from a naïve B6 mouse. Milky spots are seen within adipose at the tissue periphery. Images are representative of omental tissues harvested from B6
mice at 1, 3, 6, and 9 weeks after injection. B: Quantitation of adipocyte area from H&E images; the percent adipocyte area was normalized to the whole
omental area. Data are expressed as means  SEM (n Z 5 independent animals per time point). A linear regression of the data points indicates a slope
signiﬁcantly deviant from zero (P < 0.0001; R2 Z 0.8145) Original magniﬁcation: 50.
Clark et allodging in peritoneal adipose and provided clear data
showing that milky spots dramatically enhance early cancer
cell lodging.
To dissect the mechanism or mechanisms by which
milky spots promote colonization, we made use of the
observation that, after intraperitoneal injection, ovarian
cancer cells rapidly localize to omental milky spots, which
suggests involvement of one or more tissue-secreted
factors. Development of a quantitative Transwell migra-
tion approach (Figure 3) enabled us to assess the ability of
fat tissueeconditioned medium to stimulate directed
migration of ovarian cancer cells. Although milky
spotedeﬁcient tissues (uterine fat, gonadal fat, and
mesentery) secrete one or more factors that promote
directed migration, results from in vivo assays indicate that
this signal is not sufﬁcient for ovarian cancer cells to
achieve the high level (both in number and size) of foci
formation that is seen in the omentum and splenoportal
fat. This suggests that colonization requires additional
chemotactic signals and/or tissue structures. In support of
this notion, our in vivo assays showed that ovarian cancer
cells efﬁciently colonize milky spots in the omentum and
splenoportal fat. In addition, using medium conditioned
by milky spotecontaining adipose yielded the novel
ﬁnding that the presence of these structures caused
a signiﬁcant enhancement in the ability of the medium to
promote directed cancer migration.
Although milky spot structures comprise a number of
cell types, their importance in multiple facets of immune
defense prompted us to ask what effect the host immune
status has on the number of milky spots or on their ability
to be colonized by cancer cells. Ostensibly, it would seem588that immunodeﬁcient mice would have fewer or smaller
milky spots (because of their immunodeﬁciency) and that
these structures would therefore be poorly colonized by
cancer cells. Use of a novel virtual whole-mount technique
enabled the quantitation of milky spot volume for the ﬁrst
time in various mouse strains. These data showed that the
immune status of the host affects neither milky spot
volume (in naïve omenta) nor its colonization by cancer
cells (cancer burden) after intraperitoneal injection.
Finally, the role of adipocytes in supplying energy for
cancer cell growth is supported by the direct relationship
between cancer cell growth and adipocyte depletion.
Interestingly, this ﬁnding is in accord with breast cancer
models in which cancer growth causes a reduction in
adipocyte number and size (reducing the ratio of
adipocyte-to-cancer area), implying lipolysis and possible
adipocyte dedifferentiation.50
A large body of evidence has established the critical
importance of milky spots to ovarian cancer cell lodging and
initial colonization of peritoneal adipose3,6,24,28,40e44 and
provides a foundation for studies to identify milky spot
components involved in cancer cell homing and invasion.
As a ﬁrst step toward this goal, the use of immunodeﬁcient
mouse strains allowed us to rule out a requirement for B
cells, T cells, or NK cells for ovarian cancer cell lodging
within milky spots, thus conﬁrming and expanding on the
ﬁndings of Lotan et al.8 Previous studies have shown that
mast cells and macrophages are frequently observed in the
milky spots.30,33,34,36 Macrophages are an intriguing
candidate, because they have been shown to assist the
survival and growth of established tumors.51e53 Further-
more, the depletion of peritoneal macrophages has beenajp.amjpathol.org - The American Journal of Pathology
Ovarian Cancer Colonizes Milky Spotsshown to decrease ovarian cancer tumor burden on the
diaphragm at the experimental endpoint.54 Milky spot
macrophages are thus possible contributors to the rapid and
speciﬁc colonization of omental milky spots. Another
possible source of the chemotactic properties of the
omentum is the abundance of endothelial cells found in the
milky spots. The vessels within the dense and tangled
capillary bed of the milky spots have been shown to
undergo a constitutive level of active vascular remodel-
ing.28,42 The activated endothelial cells associated with
angiogenic vessels are known to support and promote
metastatic disease.55,56 Either or both of those cell types
could be responsible for the proliﬁc omental metastases and
warrant further study.
The growing emphasis on the role of the host tissue
microenvironment in metastasis formation stems from the
seminal work of Stephen Paget, who in 1889 showed that
certain tumor cells (metaphorically thought of as the seed)
have a proclivity for speciﬁc organ microenvironments
(the soil).57e59 A powerful but often underappreciated
aspect of studies by Paget and other pioneers of metastasis
research was their innate appreciation of the unique tissue
architecture, physiology, and function of the target organ
that is essential to understanding metastatic organ spe-
ciﬁcity.60e63 With our present studies, we have sought to
integrate milky spot and adipocyte function in the
omentum.
We propose a two-step model for omental colonization
in which the localization of disseminated cancer cells is
dependent on milky spots. Adipocytes are then required
for progressive growth and subsequent spread of cancer
cells to other sites within the peritoneal cavity. This model
is likely a more accurate representation of the overall
process of ovarian metastatic colonization. It is our hope
that both our ﬁndings and our discussion of the larger
literature will serve as a framework for studies that will
continue to reﬁne our understanding of omental coloni-
zation. Ultimately, it is our goal to use this information to
extend the duration of metastatic suppression and signif-
icantly increase the quality of life for patients diagnosed
with ovarian cancer.Acknowledgments
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